SPAC Translational Development Acquisition files for a $150 million IPO, led by the founder of Stone Capital Partners
Translational Development Acquisition, a blank check company backed by Stone Capital Partners, filed on Tuesday with the SEC to raise up to $150 million in an initial public offering. The SPAC previously filed in 2022, but the offering was declared abandoned...read more